The Europe Pet Diabetes Care Market is expected to witness market growth of 7.6% CAGR during the forecast period (2022-2028).
Maintaining the pet's approved insulin dosage and feeding schedules is crucial. Additionally, it is crucial for the pet to keep a healthy appetite while receiving insulin therapy. If the pet is not eating enough sweets to counteract the effects of the insulin, which remove carbohydrates from the bloodstream, pet owners run the danger of hypoglycemia, or low blood sugar. Also, pet parents must frequently monitor the sugar levels in the pet's blood and urine. Monitoring the pet's blood & urine glucose levels at home can complement routine checkups and testing by the veterinarian.
Keep an eye out for the warning indications of an insulin overdose that include weakness, tremors or seizures, and lack of appetite. If individuals notice any of these symptoms, call a veterinarian or an emergency clinic right away. People should also speak with their vet about what they can do to care for their pet until it could be seen by a vet. It is crucial that adjustments to the amount and quantity of insulin injections only be done by a veterinarian because the symptoms of an insulin overdose as well as an insulin underdose can occasionally be extremely similar.
The prevalence of various key players across this region is among the key aspects augmenting the regional market growth. Diabetes impairs a pet's ability to effectively utilize glucose, a form of sugar found in blood that serves as the body's principal fuel supply for all cells. The hormone insulin, which really is mainly responsible for controlling blood sugar levels, is either not generated at all or in inadequate amounts in diabetic pets. Animals with diabetes, like most people with the condition, require regular daily insulin injections to prevent life-threatening consequences from their illness.
The Germany market dominated the Europe Pet Diabetes Care Market by Country in 2021, and is expected to continue to be a dominant market till 2028; thereby, achieving a market value of $159.7 million by 2028. The UK market is anticipated to grow at a CAGR of 6.7% during (2022 - 2028). Additionally, The France market is expected to exhibit a CAGR of 8.4% during (2022 - 2028).
Based on Animal Type, the market is segmented into Dogs and Cat. Based on Distribution Channel, the market is segmented into Veterinary Hospitals & Clinics, Retail Pharmacies, and E-commerce. Based on Solution, the market is segmented into Treatment (Insulin Therapy, Insulin Delivery Devices, and Others) and Glucose Monitoring Devices. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Boehringer Ingelheim International GmbH, Becton, Dickinson and Company, Merck & Co., Inc., Zoetis, Inc., ACON Laboratories, Inc., Allison Medical, Inc., i-SENS, Inc., Trividia Health, Inc., UltiMed, Inc., and Taidoc Technology Corporation.
Maintaining the pet's approved insulin dosage and feeding schedules is crucial. Additionally, it is crucial for the pet to keep a healthy appetite while receiving insulin therapy. If the pet is not eating enough sweets to counteract the effects of the insulin, which remove carbohydrates from the bloodstream, pet owners run the danger of hypoglycemia, or low blood sugar. Also, pet parents must frequently monitor the sugar levels in the pet's blood and urine. Monitoring the pet's blood & urine glucose levels at home can complement routine checkups and testing by the veterinarian.
Keep an eye out for the warning indications of an insulin overdose that include weakness, tremors or seizures, and lack of appetite. If individuals notice any of these symptoms, call a veterinarian or an emergency clinic right away. People should also speak with their vet about what they can do to care for their pet until it could be seen by a vet. It is crucial that adjustments to the amount and quantity of insulin injections only be done by a veterinarian because the symptoms of an insulin overdose as well as an insulin underdose can occasionally be extremely similar.
The prevalence of various key players across this region is among the key aspects augmenting the regional market growth. Diabetes impairs a pet's ability to effectively utilize glucose, a form of sugar found in blood that serves as the body's principal fuel supply for all cells. The hormone insulin, which really is mainly responsible for controlling blood sugar levels, is either not generated at all or in inadequate amounts in diabetic pets. Animals with diabetes, like most people with the condition, require regular daily insulin injections to prevent life-threatening consequences from their illness.
The Germany market dominated the Europe Pet Diabetes Care Market by Country in 2021, and is expected to continue to be a dominant market till 2028; thereby, achieving a market value of $159.7 million by 2028. The UK market is anticipated to grow at a CAGR of 6.7% during (2022 - 2028). Additionally, The France market is expected to exhibit a CAGR of 8.4% during (2022 - 2028).
Based on Animal Type, the market is segmented into Dogs and Cat. Based on Distribution Channel, the market is segmented into Veterinary Hospitals & Clinics, Retail Pharmacies, and E-commerce. Based on Solution, the market is segmented into Treatment (Insulin Therapy, Insulin Delivery Devices, and Others) and Glucose Monitoring Devices. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Boehringer Ingelheim International GmbH, Becton, Dickinson and Company, Merck & Co., Inc., Zoetis, Inc., ACON Laboratories, Inc., Allison Medical, Inc., i-SENS, Inc., Trividia Health, Inc., UltiMed, Inc., and Taidoc Technology Corporation.
Scope of the Study
Market Segments Covered in the Report:
By Animal Type
- Dogs
- Cat
By Distribution Channel
- Veterinary Hospitals & Clinics
- Retail Pharmacies
- E-commerce
By Solution
- Treatment
- Insulin Therapy
- Insulin Delivery Devices
- Others
- Glucose Monitoring Devices
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Key Market Players
List of Companies Profiled in the Report:
- Boehringer Ingelheim International GmbH
- Becton, Dickinson and Company
- Merck & Co., Inc.
- Zoetis, Inc.
- ACON Laboratories, Inc.
- Allison Medical, Inc.
- i-SENS, Inc.
- Trividia Health, Inc.
- UltiMed, Inc.
- Taidoc Technology Corporation
Unique Offerings from the Publisher
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 3. Europe Pet Diabetes Care Market by Animal Type
Chapter 4. Europe Pet Diabetes Care Market by Distribution Channel
Chapter 5. Europe Pet Diabetes Care Market by Solution
Chapter 6. Europe Pet Diabetes Care Market by Country
Chapter 7. Company Profiles
Companies Mentioned
- Boehringer Ingelheim International GmbH
- Becton, Dickinson and Company
- Merck & Co., Inc.
- Zoetis, Inc.
- ACON Laboratories, Inc.
- Allison Medical, Inc.
- i-SENS, Inc.
- Trividia Health, Inc.
- UltiMed, Inc.
- Taidoc Technology Corporation
Methodology
LOADING...
